Healthy Life Agritec reports FY26 revenue growth, net profit rises

1 min read     Updated on 23 Jun 2026, 04:46 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Healthy Life Agritec Ltd reported a 22.7% increase in consolidated net profit to ₹399.54 lakh for FY26, driven by a 32.7% rise in revenue to ₹22,814.20 lakh. The standalone net profit rose to ₹245.50 lakh. The company raised ₹2,481.20 lakh via a rights issue during the year. While auditors issued an unmodified opinion, they flagged non-compliance with TDS, PF, and ESIC regulations, along with outstanding tax liabilities and missing internal audit reports.

powered bylight_fuzz_icon
43687254

*this image is generated using AI for illustrative purposes only.

Healthy Life Agritec Ltd reported a consolidated net profit of ₹399.54 lakh for the year ended March 31, 2026, an increase from ₹325.56 lakh in the previous year. Revenue from operations for the period rose to ₹22,814.20 lakh, compared to ₹17,187.06 lakh in FY25. The company's board approved the audited standalone and consolidated financial results on June 8, 2026, following a delay attributed to the late receipt of financial statements from a subsidiary.

The statutory auditors, NYS & Company, issued an unmodified opinion on the financial results. However, the audit report highlighted key matters, including non-compliance with Tax Deducted at Source (TDS) regulations and Employees' Provident Fund and Employees' State Insurance provisions. The company also reported outstanding undisputed income tax liabilities and noted that the Internal Audit Report and Report on Internal Financial Control were not available for verification at the time of the report.

Financial Performance

For the standalone financial results, the company reported a net profit of ₹245.50 lakh for FY26, up from ₹186.77 lakh in the previous year. Revenue from operations stood at ₹10,707.20 lakh. Earnings per share (EPS) on a basic basis for the year stood at ₹0.49, compared to ₹0.75 in the prior year, impacted by the expansion of the equity base.

During the year, the company raised ₹2,481.20 lakh through a rights issue of 24,812,000 equity shares with a face value of ₹10 each. The funds were primarily utilized for working capital requirements and general corporate purposes, with no deviation from the stated objects as monitored by Care Ratings Limited.

Consolidated Results Summary

Metric FY26 (₹ Lacs) FY25 (₹ Lacs)
Revenue from operations 22,814.20 17,187.06
Total expenses 22,272.32 16,751.81
Net profit 399.54 325.56
Basic EPS (₹) 0.81 1.31

The company confirmed that the delay in filing the results was neither intentional nor deliberate, reaffirming its commitment to timely compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Healthy Life Agritec

1 Day5 Days1 Month6 Months1 Year5 Years
-4.90%-11.80%+8.11%-46.46%-82.89%+15.84%

How does the company plan to address the non-compliance issues regarding TDS and EPF/ESI provisions to prevent future regulatory penalties?

What impact will the recent equity base expansion have on future earnings per share and shareholder value?

Will the company implement measures to ensure timely receipt of financial statements from subsidiaries to avoid reporting delays?

Healthy Life Agritec FY26 net profit rises 22.7% to ₹399.54 lakh

2 min read     Updated on 10 Jun 2026, 01:41 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Healthy Life Agritec Limited reported a 22.7% increase in consolidated net profit to ₹399.54 lakh for FY26, with revenue rising 32.7% to ₹22,814.20 lakh. The company raised ₹2,481.20 lakh via a rights issue to fund working capital and debt repayment. Auditors flagged TDS compliance issues and delays in GST filings.

powered bylight_fuzz_icon
42212318

*this image is generated using AI for illustrative purposes only.

Healthy Life Agritec Limited reported a consolidated net profit of ₹399.54 lakh for the financial year ended March 31, 2026, marking a 22.7% increase from ₹325.56 lakh in the previous year. Revenue from operations surged 32.7% to ₹22,814.20 lakh from ₹17,187.06 lakh in FY25, driven by robust operational performance across its subsidiaries. The company raised ₹2,481.20 lakh during the year through a rights issue of 24,812,000 equity shares with a face value of ₹10 each, primarily to fund working capital requirements and general corporate purposes. The audited financial results were published in the Financial Express and Jansatta newspapers on June 10, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The board approved the audited standalone and consolidated financial results for FY26 at its meeting held on June 08, 2026. Statutory auditors M/s NYS & Company issued an unmodified opinion on the results. The auditors highlighted key matters, including irregularities in Tax Deducted at Source (TDS) compliance and non-provision of late payment charges. The company also faces outstanding undisputed income tax liabilities and delays in GST return filings. Additionally, internal audit reports and reports on internal financial controls were not available for verification as of the report date.

Operational Performance

For the quarter ended March 31, 2026, the company recorded a consolidated net profit of ₹104.99 lakh, compared to ₹82.37 lakh in the corresponding period of the previous year. Quarterly revenue from operations stood at ₹8,519.24 lakh, significantly higher than the ₹4,355.25 lakh reported in Q4 FY25.

On a standalone basis, net profit for FY26 rose to ₹245.50 lakh from ₹186.77 lakh in FY25. Revenue from operations increased to ₹10,707.20 lakh from ₹6,445.06 lakh in the prior year. The board also noted that the trading window for designated persons, closed since April 01, 2026, will reopen 48 hours after the declaration of results.

Financial Highlights

Metric FY26 (₹ Lakh) FY25 (₹ Lakh)
Consolidated Revenue 22,814.20 17,187.06
Consolidated Net Profit 399.54 325.56
Standalone Revenue 10,707.20 6,445.06
Standalone Net Profit 245.50 186.77
Total Equity 6,317.04 3,436.31

Fund Utilization

The monitoring agency, Care Ratings Limited, reported no deviation in the utilization of funds raised via the rights issue. Proceeds were utilized for working capital requirements (₹1,800.34 lakh), repayment of debt (₹85.00 lakh), and general corporate purposes (₹564.89 lakh).

Historical Stock Returns for Healthy Life Agritec

1 Day5 Days1 Month6 Months1 Year5 Years
-4.90%-11.80%+8.11%-46.46%-82.89%+15.84%

What specific measures will management implement to address the auditor's concerns regarding TDS compliance and GST filing delays?

How does the company plan to sustain the 32.7% revenue growth rate in FY27 given the cyclical nature of the agritech sector?

Will the recent rights issue proceeds be sufficient to meet long-term working capital needs, or is further equity dilution anticipated?

More News on Healthy Life Agritec

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-82.89%